New England Biolabs, Inc Overview
Company Headquarters: Massachusetts, US
Founded: 1974
Workforce: ~350
Company Working: New England Biolabs, Inc. is a biotechnology company. It offers over 200 recombinant and 30 native restriction enzymes for genomic research, along with DNA methylases and nicking enzymes. Additionally, it emphasizes sample preparation for RNA analysis, polymerase chain reaction (PCR), synthetic biology, glycobiology, gene expression, epigenetics, and next-generation sequencing. New England Biolabs has a wide international distribution thanks to a network of agents, exclusive distributors, and eight subsidiaries with locations in Australia, Canada, China, France, Germany, Japan, Singapore, and the UK. The company also places a strong emphasis on the advancement of molecular diagnostics. The company serves clients from all over the world.
Strategy
New England Biolabs is aiming to discover and develop native and recombinant enzymes for genomic research. Its goal is to offer the best possible technical support and product quality. Additionally, it is striving to strengthen partnerships that help new technologies enter important market segments like molecular diagnostics. Moreover, it is also aiming to improve the partnerships that give cutting-edge gene technology access to significant market areas like the development of molecular diagnostics.
